Mycobacterium tuberculosis strains resistant to almost all available anti-tuberculosis drugs
are an increasing threat to public health worldwide. Among existing drugs with potential …

MDR TB living in this region may be much higher because a substantial proportion of patients
are never screened for drug-resistant TB before starting treatment, partly because of a lack …

Treatment Outcomes in Multidrug-Resistant Tuberculosis | NEJM Skip to main content NEJM
Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a …

Objectives To evaluate the access to comprehensive diagnostics and novel antituberculosis
medicines in European countries. Methods We investigated the access to genotypic and …

The combination of meropenem with clavulanate has high antimycobacterial activity in vitro
against extensively drug-resistant Mycobacteriumtuberculosis strains. We report the …

ABSTRACT Background Immunotherapy represents a recent milestone in the treatment of
lung cancer, particularly with the rapidly expanding development of monoclonal antibodies …

Rationale: Multidrug-resistant tuberculosis (MDR-TB) is a major burden to public health in
Europe. Reported treatment success rates are around 50% or less, and cure rates are even …

Background European-specific policies for tuberculosis (TB) elimination require identification
of key populations that benefit from TB screening. Aim We aimed to identify groups of …

Background Objectives: To determine whether the incidence of tuberculosis with pregnancy
is more common than would be expected from the crude birth rate; to see whether there is …

Questionnaires play a key place in the assessment of asthma control. Different questionnaires
have been developed. However, it remains largely unknown whether they can be used …